Terms: = Prostate cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45
129 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Cell Therapy by Mesenchymal Stromal Cells Versus Myoblasts in a Pig Model of Urinary Incontinence.
Knoll J; Amend B; Harland N; Isser S; Bézière N; Kraushaar U; Stenzl A; Aicher WK
Tissue Eng Part A; 2024 Jan; 30(1-2):14-30. PubMed ID: 37933911
[TBL] [Abstract] [Full Text] [Related]
3. Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells.
Filon M; Yang B; Purohit TA; Schehr J; Singh A; Bigarella M; Lewis P; Denu J; Lang J; Jarrard DF
Oncotarget; 2023 Jul; 14():738-746. PubMed ID: 37477521
[TBL] [Abstract] [Full Text] [Related]
4. [Exosomes derived from mesenchymal stem cells loaded with annexin A2 reduce the polarization of M2 macrophages to inhibit the growth of prostate cancer cells in nude mice].
Tian Y; Guo X; Cheng J; Wang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Feb; 39(2):109-116. PubMed ID: 36872428
[TBL] [Abstract] [Full Text] [Related]
5. Multiplicative, additive, and interactive associations of 25-hydroxyvitamin D with lung and prostate cancer.
Voutilainen A; Virtanen JK; Hantunen S; Nurmi T; Kokko P; Tuomainen TP
Int J Vitam Nutr Res; 2024 Apr; 94(2):133-142. PubMed ID: 36755523
[No Abstract] [Full Text] [Related]
6. Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.
Limaye S; Chowdhury S; Rohatgi N; Ranade A; Syed N; Riedemann J; Patil D; Akolkar D; Datta V; Patel S; Chougule R; Shejwalkar P; Bendale K; Apurwa S; Schuster S; John J; Srinivasan A; Datar R
Cancer Med; 2023 Apr; 12(8):9116-9127. PubMed ID: 36718027
[TBL] [Abstract] [Full Text] [Related]
7. Artifactual Cystic Spaces in Prostatic Transurethral Resections and Related Specimens: A Potential Diagnostic Confounder.
Sangoi AR; Akgul M; Williamson SR
Int J Surg Pathol; 2023 Sep; 31(6):1048-1056. PubMed ID: 36314458
[No Abstract] [Full Text] [Related]
8. The role of bile acids in carcinogenesis.
Režen T; Rozman D; Kovács T; Kovács P; Sipos A; Bai P; Mikó E
Cell Mol Life Sci; 2022 Apr; 79(5):243. PubMed ID: 35429253
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia-inducible factor-1α inhibition augments efficacy of programmed cell death 1 antibody in murine prostatic cancer models.
Shen Z; Pei Q; Zhang H; Yang C; Cui H; Li B; Liu J; Bo Z; Wei F; Zhang M; Liu C
Anticancer Drugs; 2022 Jul; 33(6):587-594. PubMed ID: 35324523
[TBL] [Abstract] [Full Text] [Related]
10. Splice-disrupt genomic variants in prostate cancer.
Alanazi IO; Alamery SF; Ebrahimie E; Mohammadi-Dehcheshmeh M
Mol Biol Rep; 2022 Jun; 49(6):4237-4246. PubMed ID: 35286517
[TBL] [Abstract] [Full Text] [Related]
11. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
[TBL] [Abstract] [Full Text] [Related]
12. Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole Blood.
Undvall Anand E; Magnusson C; Lenshof A; Ceder Y; Lilja H; Laurell T
Anal Chem; 2021 Dec; 93(51):17076-17085. PubMed ID: 34913344
[TBL] [Abstract] [Full Text] [Related]
13. Men's preferences for image-guidance in prostate radiation therapy: A discrete choice experiment.
Brown A; Pain T; Tan A; Anable L; Callander E; Watt K; Street D; De Abreu Lourenco R
Radiother Oncol; 2022 Feb; 167():49-56. PubMed ID: 34890737
[TBL] [Abstract] [Full Text] [Related]
14. Biosensors for circulating tumor cells (CTCs)-biomarker detection in lung and prostate cancer: Trends and prospects.
Hussain SH; Huertas CS; Mitchell A; Deman AL; Laurenceau E
Biosens Bioelectron; 2022 Feb; 197():113770. PubMed ID: 34768065
[TBL] [Abstract] [Full Text] [Related]
15. Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate.
Desai AS; Sagar V; Lysy B; Weiner AB; Ko OS; Driscoll C; Rodriguez Y; Vatapalli R; Unno K; Han H; Cohen JE; Vo AX; Pham M; Shin M; Jain-Poster K; Ross J; Morency EG; Meyers TJ; Witte JS; Wu J; Abdulkadir SA; Kundu SD
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):463-471. PubMed ID: 34035460
[TBL] [Abstract] [Full Text] [Related]
16. Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models.
Metzen M; Bruns M; Deppert W; Schumacher U
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921688
[TBL] [Abstract] [Full Text] [Related]
17. Identifying Risk Profiles of Malignant prostate cancer Surgical Delay Using a Person-Centered Approach to Understand prostate cancer Disparities: The Constellation of Health Determinants Using Latent Class Analysis on cancer Registry Data.
Montiel Ishino FA; Rowan C; Das R; Thapa J; Cobran E; Whiteside M; Williams F
Am J Mens Health; 2020; 14(6):1557988320984282. PubMed ID: 33372564
[TBL] [Abstract] [Full Text] [Related]
18. Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive prostate cancer and Reversing Immunosuppression: Serum and Biopsy
Ganaie AA; Mansini AP; Hussain T; Rao A; Siddique HR; Shabaneh A; Ferrari MG; Murugan P; Klingelhöfer J; Wang J; Ambartsumian N; Warlick CA; Konety BR; Saleem M
Mol Cancer Ther; 2020 Dec; 19(12):2598-2611. PubMed ID: 32999046
[TBL] [Abstract] [Full Text] [Related]
19. The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.
Nickols NG; Ganapathy E; Nguyen C; Kane N; Lin L; Diaz-Perez S; Nazarian R; Mathis C; Felix C; Basehart V; Zomorodian N; Kwak J; Kishan AU; King CR; Kupelian PA; Rettig MB; Steinberg ML; Cao M; Knudsen BS; Chu FI; Romero T; Elashoff D; Reiter RE; Schaue D
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):135-139. PubMed ID: 32647353
[TBL] [Abstract] [Full Text] [Related]
20. Database Mining of Genes of Prognostic Value for the prostate Adenocarcinoma Microenvironment Using the cancer Gene Atlas.
Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
[TBL] [Abstract] [Full Text] [Related]
[Next]
